Examining the relationship between homelessness and drug use patterns among people on probation or parole
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
This study looks at how being on probation or parole impacts drug use, especially fentanyl and stimulants, among people who are homeless, focusing on the struggles they face after being in jail and how it affects their chances of overdose, particularly for those from racially minoritized groups.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10841820 on NIH RePORTER |
What this research studies
This research investigates how community supervision, such as probation and parole, affects the patterns of drug use, particularly fentanyl and stimulants, among individuals experiencing homelessness. It aims to understand the vulnerabilities to overdose that arise during and after incarceration, especially for those who are racially minoritized. By conducting qualitative interviews, the study will explore the challenges these individuals face in accessing housing and treatment services post-release. The findings could inform policies and programs aimed at improving support for this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing homelessness who are currently on probation or parole and use fentanyl and stimulants.
Not a fit: Patients who are not experiencing homelessness or are not involved in the criminal justice system may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment and support services for homeless individuals struggling with polysubstance use, ultimately reducing overdose risks.
How similar studies have performed: While there is ongoing research into drug use and homelessness, this specific focus on community supervision and its impact on overdose vulnerability is relatively novel.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Mcneil, Ryan — Yale University
- Study coordinator: Mcneil, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.